Illumina, Inc. announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2. In this role reporting to the CEO, Dr. Green will accelerate the company's mission to drive a revolution in medicine by unlocking the power of the genome. Dr. Green will serve as a key scientif…
Jazz Pharmaceuticals plc announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026. Mr. Riga joined Jazz in April 2025 through the acquisition of Chimerix Inc., where he served as chief operating and commercial officer. In that role, he directed corporate strategy including the suc…
Viatris Inc. that Lara Ramsburg has been appointed Chief People and Corporate Affairs Officer. As part of Viatris' ongoing transformation efforts, this newly combined role is designed to continue to advance the company's culture and connectivity across the globe, while also strengthening the alignment of the organizat…
Propel Bio Partners announced the appointment of healthcare technology veteran Laurie Heilmann as Venture Partner, bringing more than three decades of commercialization and operational expertise to support the firm's investment strategy and portfolio companies from early development through successful exits. Heilman…
SHINE announced that it has completed its acquisition of Lantheus' SPECT business, including the North Billerica, Massachusetts SPECT manufacturing facility and its portfolio of diagnostic radiopharmaceuticals. The acquisition brings immediate revenue and operational scale in the $19 billion nuclear medicine market. S…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the appointment of Simon Dingemans to its Board of Directors, effective January 2, 2026. Mr. Dingemans is an accomplished executive with extensive global l…
Advancium Health Network and its nonprofit subsidiary CobiCure announced the appointment of Michele Cleary, PhD, to Chief Executive Officer. Dr. Cleary, previously Advancium's President and Chief Scientific Officer, brings more than two decades of leadership in scientific innovation, drug development, and patient advo…
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, announced the appointment of Rick Fair as Chief Executive Officer and member of the Board of Directors of Enliven, effective December 11, 2025. Sam Kintz, Co-Founder and forme…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the appointment of Sanjeev Mehra to its Board of Directors, effective immediately. Mr. Mehra is Co-Founder and serves as Managing Partner of Periphas Cap…
Metagenics, announced it has named Patrick Sly as CEO, effective immediately. A highly regarded executive in the health and wellness industry, Mr. Sly brings a wealth of relevant leadership experience to Metagenics. Current President and CEO Pat Smallcombe, who has led Metagenics through a period of tremendous growth …
Page 6 of 14